Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Cancer patients who had breakthrough COVID-19 remain at high risk for hospitalization, death

Cancer patients who had breakthrough COVID-19 remain at high risk for hospitalization, death

LJI researchers discover how loss of TET enzymes can lead to B cell lymphoma

LJI researchers discover how loss of TET enzymes can lead to B cell lymphoma

Amino acid valine plays a key role in the growth of T cell acute lymphoblastic leukemia

Amino acid valine plays a key role in the growth of T cell acute lymphoblastic leukemia

Researchers discover new function of protein tBID

Researchers discover new function of protein tBID

Booster shots improve CD8+ T cell response to SARS-CoV-2 in animal model

Booster shots improve CD8+ T cell response to SARS-CoV-2 in animal model

Study reveals chromosome-level changes that relate to drug resistance in melanoma

Study reveals chromosome-level changes that relate to drug resistance in melanoma

A nematode infection can become severe and deadly with the use of corticosteroids

A nematode infection can become severe and deadly with the use of corticosteroids

Scientists develop new immunotherapy for cancer based on transplant rejection mechanism

Scientists develop new immunotherapy for cancer based on transplant rejection mechanism

Researchers map how the HTLV-1 virus causes a rare leukemia in some people

Researchers map how the HTLV-1 virus causes a rare leukemia in some people

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Study reveals molecular players involved in the onset of leukemia

Study reveals molecular players involved in the onset of leukemia

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

Researchers uncover a key role for SIRT1 enzyme in T-cell acute lymphoblastic leukemia

Researchers uncover a key role for SIRT1 enzyme in T-cell acute lymphoblastic leukemia

Study finds new treatment option for patients with relapsed or refractory peripheral T-cell lymphoma

Study finds new treatment option for patients with relapsed or refractory peripheral T-cell lymphoma

Combination treatment can provide long remissions for young patients with chronic lymphocytic leukemia

Combination treatment can provide long remissions for young patients with chronic lymphocytic leukemia

Drug combination without chemotherapy can be effective in treating older patients with Ph+ ALL

Drug combination without chemotherapy can be effective in treating older patients with Ph+ ALL

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

Evaluating the virucidal activity of blue LED light against SARS-CoV-2 infection

Novel immunotherapy shows promise for children, young adults with recurrent AML

Novel immunotherapy shows promise for children, young adults with recurrent AML

Statistical models predict outcomes for patients receiving non-intensive AML therapy

Statistical models predict outcomes for patients receiving non-intensive AML therapy

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.